OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19
Gangireddy Navitha Reddy, Akanksha Jogvanshi, Sana Naikwadi, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 9, pp. 943-955
Closed Access | Times Cited: 7
Gangireddy Navitha Reddy, Akanksha Jogvanshi, Sana Naikwadi, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 9, pp. 943-955
Closed Access | Times Cited: 7
Showing 7 citing articles:
Real-world cost-effectiveness of nirmatrelvir-ritonavir as treatment for SARS-CoV-2 infection in the Belgian setting with omicron variant
Sophie Marbaix, Steven Simoens, Philippe Clevenbergh, et al.
Frontiers in Public Health (2025) Vol. 12
Open Access
Sophie Marbaix, Steven Simoens, Philippe Clevenbergh, et al.
Frontiers in Public Health (2025) Vol. 12
Open Access
Design and Characterization of Bispecific and Trispecific Antibodies Targeting SARS-CoV-2
Jiayang Wang, Qi Qian, Yushan Jiang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 255-255
Open Access
Jiayang Wang, Qi Qian, Yushan Jiang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 255-255
Open Access
Impact of some antiviral drugs on health care utilization for patients with COVID-19: a systematic review and meta-analysis
Bincai Wei, Ruhao Zhang, Huatang Zeng, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 9, pp. 993-1009
Closed Access | Times Cited: 2
Bincai Wei, Ruhao Zhang, Huatang Zeng, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 9, pp. 993-1009
Closed Access | Times Cited: 2
Structural Basis for the Inhibition of Coronaviral Main Proteases by Pf-00835231
Xuelan Zhou, xiaolu lu, Jian Li, et al.
(2023)
Open Access | Times Cited: 2
Xuelan Zhou, xiaolu lu, Jian Li, et al.
(2023)
Open Access | Times Cited: 2
Structural basis for the inhibition of coronaviral main proteases by PF-00835231
Xuelan Zhou, Xiaolu Lu, Cheng‐Wen Lin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Xuelan Zhou, Xiaolu Lu, Cheng‐Wen Lin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Structural basis for the inhibition of coronaviral main proteases by PF-00835231
Xuelan Zhou, Xiaolu Lu, Cheng‐Wen Lin, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access
Xuelan Zhou, Xiaolu Lu, Cheng‐Wen Lin, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access
Identification and evaluation of candidate COVID-19 critical genes and medicinal drugs related to plasma cells
Zhe Liu, Olutomilayo Olayemi Petinrin, Nanjun Chen, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Zhe Liu, Olutomilayo Olayemi Petinrin, Nanjun Chen, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
